Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 70426 - 70450 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	ERBB3	2065	downregulated	Silicon Dioxide analog results in decreased expression of ERBB3 mRNA	12q13.2	A24195
Silicon dioxide	Approved	ERC2-IT1	711	downregulated	Silicon Dioxide analog results in decreased expression of ERC2-IT1 mRNA	3p14.3	A24194
Silicon dioxide	Approved	ERCC6L	54821	downregulated	Silicon Dioxide analog results in decreased expression of ERCC6L mRNA	Xq13.1	A24194
Silicon dioxide	Approved	ERCC6L	54821	upregulated	Silicon Dioxide analog results in increased expression of ERCC6L mRNA	Xq13.1	A24195
Silicon dioxide	Approved	ERCC8	1161	downregulated	Silicon Dioxide results in decreased expression of ERCC8 mRNA	5q12.1	A24196
Silicon dioxide	Approved	EREG	2069	upregulated	Silicon Dioxide analog results in increased expression of EREG mRNA	4q13.3	A24195
Silicon dioxide	Approved	ERF	2077	upregulated	Silicon Dioxide analog results in increased expression of ERF mRNA	19q13.2	A24194
Silicon dioxide	Approved	ERI2	112479	downregulated	Silicon Dioxide analog results in decreased expression of ERI2 mRNA	16p12.3	A24195
Silicon dioxide	Approved	ERLIN1	10613	downregulated	Silicon Dioxide results in decreased expression of ERLIN1 mRNA	10q24.31	A24196
Silicon dioxide	Approved	ERLIN2	11160	downregulated	Silicon Dioxide results in decreased expression of ERLIN2 mRNA	8p11.23	A24196
Silicon dioxide	Approved	ERMAP	114625	downregulated	Silicon Dioxide results in decreased expression of ERMAP mRNA	1p34.2	A24196
Silicon dioxide	Approved	ERMP1	79956	downregulated	Silicon Dioxide analog results in decreased expression of ERMP1 mRNA	9p24.1	A24195
Silicon dioxide	Approved	ERP44	23071	upregulated	Silicon Dioxide results in increased expression of ERP44 mRNA	9q31.1	A24196
Silicon dioxide	Approved	ERVW-1	30816	downregulated	Silicon Dioxide analog results in decreased expression of ERVW-1 mRNA	7q21.2	A24194
Silicon dioxide	Approved	ESCO2	157570	downregulated	Silicon Dioxide analog results in decreased expression of ESCO2 mRNA	8p21.1	A24194
Silicon dioxide	Approved	ESM1	11082	upregulated	Silicon Dioxide analog results in increased expression of ESM1 mRNA	5q11.2	A24194
Silicon dioxide	Approved	ETNK1	55500	upregulated	Silicon Dioxide results in increased expression of ETNK1 mRNA	12p12.1	A24196
Silicon dioxide	Approved	ETS1	2113	upregulated	Silicon Dioxide analog results in increased expression of ETS1 mRNA	11q24.3	A24194 A24195
Silicon dioxide	Approved	ETV1	2115	downregulated	Silicon Dioxide analog results in decreased expression of ETV1 mRNA	7p21.2	A24195
Silicon dioxide	Approved	ETV5	2119	downregulated	Silicon Dioxide results in decreased expression of ETV5 mRNA	3q27.2	A24207
Silicon dioxide	Approved	EVA1A	84141	upregulated	Silicon Dioxide analog results in increased expression of EVA1A mRNA	2p12	A24195
Silicon dioxide	Approved	EVI2A	2123	upregulated	Silicon Dioxide analog results in increased expression of EVI2A mRNA	17q11.2	A24195
Silicon dioxide	Approved	EWSR1	2130	upregulated	Silicon Dioxide analog results in increased expression of EWSR1 mRNA	22q12.2	A24195
Silicon dioxide	Approved	EXD3	54932	downregulated	Silicon Dioxide analog results in decreased expression of EXD3 mRNA	9q34.3	A24195
Silicon dioxide	Approved	EXO1	9156	downregulated	Silicon Dioxide analog results in decreased expression of EXO1 mRNA	1q43	A24194

Displaying entries 70426 - 70450 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability